64 results
8-K
EX-10.2
ADAP
Adaptimmune Therapeutics Plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
or innovation, whether or not patentable or capable of registration, and whether or not recorded in any medium.
page 10 of 13
You acknowledge
8-K
EX-10.3
ADAP
Adaptimmune Therapeutics Plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
, improvement or innovation, whether or not patentable or capable of registration, and whether or not recorded in any medium.
page 10 of 13
You acknowledge
8-K
EX-10.4
ADAP
Adaptimmune Therapeutics Plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
premises or resources).
"Invention" means any invention, idea, discovery, development, improvement or innovation, whether or not patentable or capable
424B3
ADAP
Adaptimmune Therapeutics Plc
20 Apr 23
Prospectus supplement
4:32pm
company will be located in key innovation hubs and will have a deep bench of cell therapy professionals, infrastructure and end-to-end capabilities … will have greater expertise and technology access, which will allow Adaptimmune to accelerate innovation and sustain investment in rapid product
S-4/A
xjxl7i cy
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
S-4
mkpslh33
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
ydc7u2b br16
15 Jun 22
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-10.2
8qkedi
15 Jun 22
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-10.1
0cp9od3nvnmnpb3ui
15 Jun 22
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-99.1
dkl g7mhapk3xxr
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
8-K
EX-10.1
kpjzkcdp4ujr 5emk
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
8-K
z48iu0gtbd1yjvo kf
20 Aug 21
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-10.2
y3sdcdmifbahla
20 Aug 21
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-10.1
lyjinhzd
20 Aug 21
Entry into a Material Definitive Agreement
4:31pm